Abstract Background: Cannabis-based medicinal products (CBMPs) are increasingly being used to treat post-traumatic stress disorder (PTSD), despite limited evidence of…
Abstract Randomised controlled trials (RCTs) have long been considered the gold standard of medical evidence. In relation to cannabis based…
Abstract Synthetic cannabinoid receptor agonists (SCRAs) may be used as an alternative to natural cannabis; however, they may carry a…
Abstract Background: Daily use of high-potency cannabis has been reported to carry a high risk for developing a psychotic disorder.…
Abstract Aims: To quantify changes in (i) potency (concentration of Δ9‐tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value…
Abstract Liability to alcohol dependence (AD) is heritable, but little is known about its complex polygenic architecture or its genetic…
Abstract Despite moderate heritability, only one study has identified genomewide significant loci for cannabis-related phenotypes. We conducted meta-analyses of genomewide…